In HIV/HCV co-infected patients T regulatory and myeloid-derived suppressor cells persist after successful treatment with directly acting antivirals

被引：14
|
作者：
Tumino, Nicola [1 ]
Casetti, Rita [1 ]
Fabbri, Gabriele [2 ]
Cimini, Eleonora [1 ]
Romanelli, Antonella [1 ]
Turchi, Federica [1 ]
Forini, Olindo [1 ]
Bordoni, Veronica [1 ]
Antinori, Andrea [2 ]
Ammassari, Adriana [2 ]
Sacchi, Alessandra [1 ]
Agrati, Chiara [1 ]
机构：
[1] Natl Inst Infect Dis Lazzaro Spallanzani IRCCS, Dept Epidemiol Preclin Res & Adv Diagnost, Rome, Italy
[2] Natl Inst Infect Dis Lazzaro Spallanzani IRCCS, Clin Dept, Rome, Italy
来源：
JOURNAL OF HEPATOLOGY | 2017年 / 67卷 / 02期
关键词：
CHRONIC HEPATITIS-C; ANTIRETROVIRAL THERAPY; CLINICAL-SIGNIFICANCE; COINFECTED PATIENTS;
D O I：
10.1016/j.jhep.2017.03.036
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：422 / 424
页数：4
相关论文
共 50 条
  • [21] Liver fibrosis regression in HIV-HCV co-infected individuals after sustained virologic response with HCV direct-acting antivirals
    Arias, Ana
    Lledo, Gemma
    Trevino, Ana
    Benitez-Gutierrez, Laura
    Carrasco, Itziar
    Cuervas-Mons, Valentin
    De Mendoza, Carmen
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2016, 19
  • [22] First Real World Data of Treatment Outcomes with Direct Acting Antivirals in HIV-HCV co-infected patients from Manipur, India
    Hidangmayum, Diamond Sharma
    Tyagi, Satyendra
    Goswami, Bhabadev
    Singh, Bhimo
    Karam, Romeo
    Singh, Lokeshwor
    HEPATOLOGY, 2017, 66 : 809A - 810A
  • [23] Regression of Liver Stiffness after Successful HCV-Treatment and Associated Factors in HCV Mono-Infected and HCV-HIV Co-Infected Patients
    Malin, Jakob
    Boesecke, Christoph
    Schware-Zander, Carolynne
    Wasmuth, Jan Christian
    Schlabe, Stefan
    Trebicka, Jonel
    Spengler, Ulrich
    Llibre, Joseph Maria
    Jou, Toni
    Puig, Jordi
    Clotet, Bonaventura
    Rockstroh, Juergen Kurt
    HEPATOLOGY, 2018, 68 : 421A - 421A
  • [24] Expansion of myeloid-derived suppressor cells promotes differentiation of regulatory T cells in HIV-1+ individuals
    Wang, Ling
    Zhao, Juan
    Ren, Jun P.
    Wu, Xiao Y.
    Morrison, Zheng D.
    El Gazzar, Mohamed
    Ning, Shun B.
    Moorman, Jonathan P.
    Yao, Zhi Q.
    AIDS, 2016, 30 (10) : 1521 - 1531
  • [25] Time course of cellular HIV-DNA and low-level HIV viremia in HIV–HCV co-infected patients whose HCV infection had been successfully treated with directly acting antivirals
    Saverio G. Parisi
    Samantha Andreis
    Monica Basso
    Silvia Cavinato
    Renzo Scaggiante
    Marzia Franzetti
    Massimo Andreoni
    Giorgio Palù
    Anna Maria Cattelan
    Medical Microbiology and Immunology, 2017, 206 : 419 - 428
  • [26] Human pegivirus viremia in HCV/HIV co-infected patients: Direct acting antivirals exert anti-pegivirus effects
    Hlavay, B. A.
    Zhuo, R.
    Ogando, N.
    Charlton, C.
    Stapleton, J. T.
    Klein, M. B.
    Power, C.
    JOURNAL OF CLINICAL VIROLOGY, 2023, 162
  • [27] Fulminant autoimmune hepatitis after successful interferon treatment in an HIV-HCV co-infected patient
    Coriat, Romain
    Podevin, Philippe
    INTERNATIONAL JOURNAL OF STD & AIDS, 2008, 19 (03) : 208 - 210
  • [28] Successful direct-acting antiviral therapy in HIV/HCV co-infected patients fails to restore circulating mucosal-associated invariant T cells
    Cannizzo, Elvira Stefania
    Cerrone, Maddalena
    Merlini, Esther
    van Wilgenburg, Bonnie
    Swadling, Leo
    Ancona, Giuseppe
    De Bona, Anna
    Monforte, Antonella d'Arminio
    Klenerman, Paul
    Marchetti, Giulia
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2019, 49 (07) : 1127 - 1129
  • [29] Time course of cellular HIV-DNA and low-level HIV viremia in HIV-HCV co-infected patients whose HCV infection had been successfully treated with directly acting antivirals
    Parisi, Saverio G.
    Andreis, Samantha
    Basso, Monica
    Cavinato, Silvia
    Scaggiante, Renzo
    Franzetti, Marzia
    Andreoni, Massimo
    Palu, Giorgio
    Cattelan, Anna Maria
    MEDICAL MICROBIOLOGY AND IMMUNOLOGY, 2017, 206 (06) : 419 - 428
  • [30] Modulation of regulatory T cells and myeloid-derived suppressor cells by sorafenib and sunitinib in renal cell carcinoma patients
    Floercken, A.
    Takvorian, A.
    Singh, A.
    Hopfenmueller, W.
    Pezzutto, A.
    Doerken, B.
    Westermann, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
12345